The Daily Biotech Pulse: Pfizer Strikes $5.29B COVID Pill Supply Deal With US, Roche’s Spark Therapeutics Reports Positive Gene Therapy Readout, EDAP Earnings
Here's a roundup of top developments in the biotech space over the last 24 hours:
Moderna Files For Authorization Of Its COVID-19 Vaccine With Health Canada To Include Children Ages 6-11 Years
Moderna Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that it has submitted for authorization with Health Canada for the evaluation of a 50
Can Moderna Deliver A Highly Effective Flu Vaccine?
Moderna, Inc.'s (NASDAQ: MRNA) vaccine franchise has further legs to play out, according to an analyst at Morgan Stanley.
AstraZeneca, Moderna Shares Early Cut Data For mRNA Candidate In Heart Failure
Moderna Inc (NASDAQ:MRNA) announced data from the AstraZeneca Plc (NASDAQ:AZN)-led Phase 2 (EPICCURE) study evaluating AZD8601 in patients undergoing coronary artery bypass grafting…
This Is What Whales Are Betting On Moderna
A whale with a lot of money to spend has taken a noticeably bullish stance on Moderna.
Looking at options history for Moderna (NASDAQ:MRNA) we detected 24 strange trades.
Moderna Says COVID-19 Vax Associated With Fewer Cases Than Pfizer’s, But Higher Inflammatory Heart Conditions
Moderna Inc (NASDAQ:MRNA) defended using its COVID-19 vaccine, saying the protection it offers outweighs the risk of myocarditis seen…